SCHEMBL337863

SCHEMBL337863

O=C(CCC(=O)OBr)OBr

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.44
ALDH1A1 P00352 2/20 0.33
ADRA2A P08913 1/20 0.33
ADRA1A P35348 1/20 0.33
MAPT P10636 1/20 0.32
BLM P54132 1/20 0.32
KDM6B O15054 1/20 0.32
KDM5C P41229 1/20 0.32
EGLN1 Q9GZT9 1/20 0.32
PHF8 Q9UPP1 1/20 0.32
KDM2A Q9Y2K7 1/20 0.32
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
TRPA1 O75762 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27563886 0.87
SCHEMBL929304 0.86 TSHR (0.50) TSHRALDH1A1LMNA
SCHEMBL688569 0.86 TSHR (0.43) TSHRALDH1A1MAPTLMNA
SCHEMBL27882971 0.85
SCHEMBL16429438 0.83 DGKA (0.42) TSHRALDH1A1MAPTLMNA
SCHEMBL27948314 0.83
SCHEMBL718866 0.83 DGKA (0.42) TSHRALDH1A1MAPTLMNA
SCHEMBL689240 0.83 DGKA (0.42) TSHRALDH1A1MAPTLMNA
SCHEMBL504327 0.81
SCHEMBL10181317 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115636911-B Feather protein slurry with same substituent connected into two diblock polymer chains, and preparation method and application thereof 安徽工程大学 2023-05-16 CN claimed
CN-115636911-A Feather protein slurry with same substituent group connected to two diblock polymer chains as well as preparation method and application of feather protein slurry 安徽工程大学 2023-01-24 CN claimed
EP-2468847-B1 EUKARYOTIC MICROORGANISMS FOR PRODUCING LIPIDS AND ANTIOXIDANTS DSM NUTRITIONAL PRODUCTS AG (CH) 2017-03-29 EP claimed
EP-2951285-A1 COMPOSITIONS AND METHODS FOR INHIBITION OF PATHOGENIC BACTERIAL GROWTH Seres Therapeutics, Inc. (US) 2015-12-09 EP claimed
WO-2014121301-A1 COMPOSITIONS AND METHODS FOR INHIBITION OF PATHOGENIC BACTERIAL GROWTH Seres Health, Inc. (US) 2014-08-07 WO claimed
US-20130344546-A1 EUKARYOTIC MICROORGANISMS FOR PRODUCING LIPIDS AND ANTIOXIDANTS OCEAN NUTRITION CANADA, LTD. (CA) 2013-12-26 US claimed
EP-1501938-B1 ANALYSIS OF SUBSTRATE UTILIZATION BY ANIMAL OR PLANT CELLS BIOLOG INC (US) 2009-10-21 EP claimed
EP-1501938-A4 COMPARATIVE PHENOTYPE ANALYSIS OF CELLS, INCLUDING TESTING OF BIOLOGICALLY ACTIVE COMPOUNDS BIOLOG INC (US) 2007-01-03 EP claimed
EP-1501938-A2 COMPARATIVE PHENOTYPE ANALYSIS OF CELLS, INCLUDING TESTING OF BIOLOGICALLY ACTIVE COMPOUNDS BIOLOG, INC. (US) 2005-02-02 EP claimed
WO-2003089652-A2 COMPARATIVE PHENOTYPE ANALYSIS OF CELLS, INCLUDING TESTING OF BIOLOGICALLY ACTIVE COMPOUNDS BIOLOG, INC. (US) 2003-10-30 WO claimed
US-20030162164-A1 Comparative phenotype analysis of cells, including testing of biologically active compounds BIOLOG, INC. 2003-08-28 US claimed
US-5332430-A Use of thiadiazole compounds as an antifouling active ingredient WITCO GMBH (DE) 1994-07-26 US claimed
JP-61060265-A None JP disclosed
US-12605783-B2 Method for manufacturing soldered products DENSO CORPORATION (JP) 2026-04-21 US disclosed
EP-4676500-A2 MICROBIAL CONSORTIA Kanvas Biosciences, Inc (US) 2026-01-14 EP disclosed
US-20260007704-A1 MICROBIAL CONSORTIA Kanvas Biosciences, Inc. (US) 2026-01-08 US disclosed
JP-S6160265-A SOLDERING METHOD HAVING GOOD FREON CLEANING PROPERTY KEMIKOOTO:KK 1986-03-27 JP disclosed
EP-0151809-A1 Antifouling paint NIPPON OIL AND FATS COMPANY, LIMITED (JP) 1985-08-21 EP disclosed
US-4499223-A MODIFIED BY METAL COMPOUNDS; ANTIFOULING AGENTS; MARINE PAINTS; VARNISHES; SELF-POLISHING NIPPON PAINT CO., LTD. (JP) 1985-02-12 US disclosed
EP-0116432-A2 Improvements in or relating to N-(substituted-methyl)-azetidin-2-ones THE UNIVERSITY OF NOTRE DAME DU LAC (US) 1984-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260007704-A1 MICROBIAL CONSORTIA ALPI, FABP2, SI TSHR 3870/4885ALDH1A1 1308/4885ADRA2A 2421/4885
US-12605783-B2 Method for manufacturing soldered products ROS1, TFRC, MARK2 TSHR 2125/4885ALDH1A1 3515/4885ADRA2A 4267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.